NBC Connecticut

ALS Drug Gets Support of FDA Advisers in Rare Second Review

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was ...
Yahoo

FDA panel backs much-debated ALS drug in rare, 2nd review

FILE - This 2018 photo provided by Amylyx shows the company's co-founders Joshua Cohen, left, and Justin Klee in Cambridge, Mass. on Sept. 2, 2022. A closely watched experimental drug for Lou Gehrig’s ...
New York Post

FDA panel urges rejection of experimental Alzheimer’s drug

WASHINGTON — Government health advisers sharply criticized a closely watched Alzheimer’s drug on Friday, concluding there wasn’t enough evidence that the experimental drug slowed the brain-destroying ...
Yahoo

Drug meant to prevent premature births should be removed from market, FDA panel says

A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. The 14-to-1 ...
Tyler Morning Telegraph

FDA advisers give thumbs-down to Alzheimer’s drug, saying it lacks efficacy data

WASHINGTON — An experimental drug designed to slow cognitive decline in those with Alzheimer’s disease ran into a buzz saw of skepticism Friday as government advisers said there was not enough ...
CBS News

FDA panel backs much-debated ALS drug in rare second review

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was ...